Non-atherosclerotic coronary artery disease in molecular autopsy: a literature review

Abstract

Non-atherosclerotic coronary artery disease (N-ACAD) is a group of conditions affecting the coronary arteries that can result in sudden cardiac death. This group of conditions can be categorized into structural anomalies, such as collagenopathies, and functional anomalies, such as inflammatory vasculopathies, based on the pathological mechanism. The epidemiology of N-ACAD varies according to the genetic condition involved; however, these disorders are thought to represent a significant proportion of sudden cardiac deaths among young individuals, especially those with a family history of inherited cardiovascular diseases. In collagenopathies, the causes of N-ACAD are genetic, involving pathogenic mutations in several genes responsible for encoding the structural proteins of the vascular wall. Conversely, in vasculitis, etiology is multifactorial, encompassing genetic, immune, environmental, and infectious contributors that influence inflammatory processes. Notably, pathogenic variants may result in arterial dissection, aneurysm formation, rupture, and, ultimately, sudden cardiac death. When the cause of death remains unexplained following a standard post-mortem examination, the case is classified as a sudden unexplained death. In such circumstances, a post-mortem genetic investigation-referred to as a molecular autopsy-is of key importance for identifying potential inherited cardiac conditions and assessing the genetic risk within the deceased’s family, with the aim of preventing future cases of sudden cardiac death. In this literature review, we focus on the role of pathogenic variants in the pathogenesis of non-atherosclerotic coronary artery disease associated with sudden cardiac death in the young.

Keywords

Coronary heart disease / non-atherosclerotic / hereditary coronary / molecular autopsy

References

[1] Spînu M,Homorodean C,Ober MC.Optical coherence tomography-OCT for characterization of non-atherosclerotic coronary lesions in acute coronary syndromes.J Clin Med2022;11:265 PMCID:PMC8745669

[2] Herrington W,Sherliker P,Lewington S.Epidemiology of atherosclerosis and the potential to reduce the global burden of atherothrombotic disease.Circ Res2016;118:535-46

[3] D'Abbronzo G,Salzillo C.Application of digital analysis for assessment of coronary sub-occlusions in autopsy pathology: it is time to move beyond histology alone.Diagnostics2024;14:2115 PMCID:PMC11482547

[4] Salzillo C,Napolitano F.Sudden cardiac death in the young: state-of-the-art review in molecular autopsy.Curr Issues Mol Biol2024;46:3313-27 PMCID:PMC11049009

[5] Isbister J.Sudden cardiac death: an update.Intern Med J2019;49:826-33

[6] Corrado D,Thiene G.Sudden cardiac death in young people with apparently normal heart.Cardiovasc Res2001;50:399-408

[7] Risgaard B.Sudden cardiac death: a nationwide cohort study among the young.Dan Med J63:B5321.

[8] Tomassini L,Fedeli P.New insights on molecular autopsy in sudden death: a systematic review.Diagnostics2024;14:1151 PMCID:PMC11171636

[9] Skrypnyk C.Molecular autopsy by proxy: relevance for genetic counseling in rare genetic disorders.Front Genet2024;15:1400295 PMCID:PMC11163115

[10] Monda E,Limongelli G.The role of genetic testing in Marfan syndrome.Curr Opin Cardiol2024;39:162-9

[11] Salik I.Marfan syndrome. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.

[12] Mitrofanova LB.Causes and mechanisms of sudden cardiac death in children.Sud Med Ekspert2021;64:43-9

[13] Haruyama S,Kawasaki H,Kosugi S.Decision-making processes behind seeking regular cardiac checkups for individuals with Marfan syndrome: a grounded theory study.J Genet Couns2024;33:1191-203

[14] Vanem TT,Krohg-Sørensen K,Paus B.Survival, causes of death, and cardiovascular events in patients with Marfan syndrome.Mol Genet Genomic Med2018;6:1114-23

[15] Marelli S,Taurino J.Marfan syndrome: enhanced diagnostic tools and follow-up management strategies.Diagnostics2023;13:2284 PMCID:PMC10340634

[16] Zeigler SM,Jones JA.Pathophysiology and pathogenesis of Marfan syndrome. In: Halper J, editor. Progress in heritable soft connective tissue diseases. Cham: Springer International Publishing; 2021. pp. 185-206. PMCID:PMC8915437

[17] Blech B,Ingall T.Marfan syndrome presenting as spontaneous coronary artery dissection and arteriopathy.Neurologist2021;27:34-6

[18] Murad AM,Wang Y.GenTAC InvestigatorsMontalcino Aortic Consortium InvestigatorsSpontaneous coronary artery dissection is infrequent in individuals with heritable thoracic aortic disease despite partially shared genetic susceptibility.Am J Med Genet A2022;188:1448-56 PMCID:PMC9603627

[19] Halushka MK,Bartoloni G.Consensus statement on surgical pathology of the aorta from the society for cardiovascular pathology and the association for European cardiovascular pathology: II. noninflammatory degenerative diseases - nomenclature and diagnostic criteria.Cardiovasc Pathol2016;25:247-57

[20] Assavarittirong C,Nguyen PV.Vascular Ehlers-Danlos syndrome: pathological variants, recent discoveries, and theoretical approaches.Cardiol Rev2022;30:308-13

[21] Bertin L,Prati G.Spontaneous coronary artery rupture in patients with Ehlers-Danlos syndrome: mini review.Cardiovasc Revasc Med2022;40:231-4

[22] Buso G,Fusco EM.Current evidence and future perspectives in the medical management of vascular Ehlers-Danlos syndrome: focus on vascular prevention.J Clin Med2024;13:4255

[23] Alqahtani M,Gaudry M.Endovascular management of vascular complications in Ehlers-Danlos syndrome type IV.J Clin Med2022;11:6344

[24] Frank M,Ranque B.The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome.Eur J Hum Genet2015;23:1657-64

[25] Byers PH,Black J.Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome.Am J Med Genet C Semin Med Genet2017;175:40-7

[26] Demirdas S,Lechner R.Vascular Ehlers-Danlos syndrome: a comprehensive natural history study in a dutch national cohort of 142 patients.Circ Genom Precis Med2024;17:e003978 PMCID:PMC11188628

[27] Jost ZT,Lertwilaiwittaya P.Coronary artery aneurysm in Loeys-Dietz syndrome: a case report.Eur Heart J Case Rep2022;6:ytac204 PMCID:PMC9161713

[28] Nickol JL,Yetman AT.Case report of Loeys-Dietz syndrome presenting with coronary artery aneurysm.Eur Heart J Case Rep2022;6:ytac383 PMCID:PMC9552997

[29] Verstraeten A,Baranowska AA.European/International Fibromuscular dysplasia registry and initiative (FEIRI)collaborators of the european/international fibromuscular dysplasia registry and initiative (FEIRI)Enrichment of rare variants in Loeys-Dietz syndrome genes in spontaneous coronary artery dissection but not in severe fibromuscular dysplasia.Circulation2020;142:1021-4

[30] Chmielewski P,Michalak E.Cardiovascular involvement and prognosis in Loeys-Dietz syndrome.Kardiol Pol2023;81:1096-102

[31] Gouda P,Habib M,Aziza E.Clinical features and complications of Loeys-Dietz syndrome: a systematic review.Int J Cardiol2022;362:158-67

[32] Dey S,Frishman WH.Genetic problems, diagnosis, and cardiovascular manifestations of Loeys-Dietz syndrome.Cardiol Rev2024;32:513-8

[33] Tian M,Zhang Y,Chen J.Surgical treatment of Loeys-Dietz syndrome in a 3-year-old: case report and review of literature.Transl Pediatr2020;9:695-701 PMCID:PMC7658765

[34] Velchev JD,Luyckx I,Loeys B.Loeys-Dietz syndrome. In: Halper J, editor. Progress in heritable soft connective tissue diseases. Cham: Springer International Publishing; 2021. pp. 251-64.

[35] Loeys BL.Loeys-Dietz syndrome. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2024.

[36] Van Laer L, Dietz H, Loeys B. Loeys-Dietz syndrome. In: Halper J, editor. Progress in heritable soft connective tissue diseases. Dordrecht: Springer Netherlands; 2014. pp. 95-105.

[37] Micha D,Hilhorst-Hofstee Y.SMAD2 mutations are associated with arterial aneurysms and dissections.Hum Mutat2015;36:1145-9

[38] Salzillo C,Basso C,De Leonardis F.Sudden cardiac death caused by Kawasaki coronary artery vasculitis in a child with Hodgkin’s lymphoma. case report and literature review.Cardiovasc Pathol2025;74:107700

[39] Morana E,Andreozzi L.Coronary arteries lesions in Kawasaki disease: risk factors in an italian cohort.Biomedicines2024;12:2010 PMCID:PMC11429242

[40] Owens AM.Kawasaki disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.

[41] Gori T.Coronary vasculitis.Biomedicines2021;9:622 PMCID:PMC8226826

[42] Khanna S,Goh DSL.Coronary artery vasculitis: a review of current literature.BMC Cardiovasc Disord2021;21:7 PMCID:PMC7788693

[43] Gaspari M, Ascione A, Baldovini C, et al; Italian study group of cardiovascular pathology. Cardiovascular pathology in vasculitis.Pathologica2024;116:78-92 PMCID:PMC11138763

[44] González-Gay MÁ,Blázquez-Sánchez T.Genetics of vasculitis.Best Pract Res Clin Rheumatol2024;38:101969

[45] Onouchi Y,Burns JC.Japan Kawasaki Disease Genome ConsortiumUS Kawasaki Disease Genetics ConsortiumA genome-wide association study identifies three new risk loci for Kawasaki disease.Nat Genet2012;44:517-21

[46] Carmona FD,González-Gay MA.Genetics of vasculitis.Curr Opin Rheumatol2015;27:10-7

[47] Liu J,Pang Y.ITPKC polymorphism (rs7251246 T > C), coronary artery aneurysms, and thrombosis in patients with Kawasaki disease in a southern han Chinese population.Front Immunol2023;14:1184162

[48] Wang Y,Zhang L.The rs7404339 AA genotype in CDH5 contributes to increased risks of Kawasaki disease and coronary artery lesions in a southern chinese child population.Front Cardiovasc Med2022;9:760982 PMCID:PMC9095914

[49] Fujiwara H.Pathology of the heart in Kawasaki disease.Pediatrics1978;61:100-7.

[50] Fujiwara T,Nakano H.Pathological features of coronary arteries in children with Kawasaki disease in which coronary arterial aneurysm was absent at autopsy. Quantitative analysis.Circulation1988;78:345-50

[51] Trinidad B,Lala V.Takayasu Arteritis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.

[52] Somashekar A.Updates in the diagnosis and management of Takayasu’s arteritis.Postgrad Med2023;135:14-21

[53] Bhandari S,Ishfaq A.Pathophysiology, diagnosis, and management of takayasu arteritis: a review of current advances.Cureus2023;15:e42667 PMCID:PMC10386905

[54] Misra DP,Rathore U.Management of takayasu arteritis.Best Pract Res Clin Rheumatol2023;37:101826

[55] Onen F.Epidemiology of takayasu arteritis.Presse Med2017;46:e197-203

[56] Renauer P.The genetics of takayasu arteritis.Presse Med2017;46:e179-87 PMCID:PMC5753771

[57] Terao C,Kimura A.Two susceptibility loci to takayasu arteritis reveal a synergistic role of the IL12B and HLA-B regions in a Japanese population.Am J Hum Genet2013;93:289-97 PMCID:PMC3738822

[58] Renauer PA,Coit P.Identification of susceptibility loci in IL6, RPS9/LILRB3, and an intergenic locus on chromosome 21q22 in takayasu arteritis in a genome-wide association study.Arthritis Rheumatol2015;67:1361-8

[59] Kauferstein S.Postmortem genetic analysis following sudden cardiac death : background, approach, and future.Herzschrittmacherther Elektrophysiol2024;35:31-8

[60] Kelly KL,Basso C.Sudden cardiac death in the young: a consensus statement on recommended practices for cardiac examination by pathologists from the society for cardiovascular pathology.Cardiovasc Pathol2023;63:107497

[61] Salzillo C,Imparato A,Lucà S,Marzullo A.Cardiovascular diseases in public health: chromosomal abnormalities in congenital heart disease causing sudden cardiac death in children.Medicina2024;60:1976. PMCID:PMC11679308

[62] Asif M,Aslam S,Chowdhury MA.The use of CRISPR-Cas9 genetic technology in cardiovascular disease: a comprehensive review of current progress and future prospective.Cureus2024;16:e57869 PMCID:PMC11078688